Valuation: DMS

Market Cap 29.03M 33.49M 27.43M 24.91M 46.68M 3.21B 46.96M 328M 127M 1.63B 126M 123M 5.19B P/E 2026 *
37.3x
P/E 2027 * 11.2x
Enterprise Value 44.43M 51.26M 41.99M 38.12M 71.44M 4.92B 71.87M 501M 194M 2.49B 193M 188M 7.95B EV / Sales 2026 *
0.78x
EV / Sales 2027 * 0.56x
Free-Float
69.9%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 53 2022-07-17
Director of Finance/CFO - 2021-12-31
Chief Tech/Sci/R&D Officer - 2018-12-31
Director TitleAgeSince
Director/Board Member 56 -
Chairman 53 2022-07-17
Director/Board Member 52 2025-06-15
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 33.49M
-0.49%-1.92%-33.64%-4.51% 12.37B
+2.29%+1.53%+11.98%+10.17% 4.28B
+1.61%-7.33%-47.04%-60.77% 1.19B
+0.21%-1.17%+15.56%+76.79% 1.06B
-0.20%-3.53%-45.79%-45.26% 1.05B
+2.36%-1.25% - - 989M
+0.66%-2.93%-40.15% - 972M
+1.14%-2.78%+32.70%+100.31% 507M
-6.11%-5.97%+33.71% - 300M
Average +0.15%-1.61%-9.09%+12.79% 2.52B
Weighted average by Cap. +0.33%-0.70%-21.40%-0.02%

Financials

2026 *2027 *
Net sales 56.8M 65.54M 53.69M 48.74M 91.35M 6.29B 91.89M 641M 248M 3.19B 246M 241M 10.17B 65.9M 76.04M 62.29M 56.55M 106M 7.3B 107M 744M 287M 3.7B 286M 279M 11.79B
Net income 800K 923K 756K 686K 1.29M 88.56M 1.29M 9.03M 3.49M 44.92M 3.47M 3.39M 143M 2.6M 3M 2.46M 2.23M 4.18M 288M 4.21M 29.34M 11.34M 146M 11.27M 11.02M 465M
Net Debt 15.4M 17.77M 14.56M 13.21M 24.77M 1.7B 24.91M 174M 67.14M 865M 66.76M 65.27M 2.76B 8M 9.23M 7.56M 6.86M 12.87M 886M 12.94M 90.27M 34.88M 449M 34.68M 33.91M 1.43B
Logo DMS
Diagnostic Medical Systems (DMS) is France's leader in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: - radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; - development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine. Products and services are marketed primarily by exclusive retailers. Net sales (not including sold divisions) are distributed geographically as follows: Europe (49.6%), North and South America (17%), Asia (7.5%), Middle East (7.5%), Africa (3.1%), Oceania (1%) and other (14.3%).
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!